Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease

Background and Purpose The substantia innominata (SI) contains the nucleus basalis of Meynert, which is the major source of cholinergic input to the cerebral cortex. We hypothesized that degeneration of the SI and its relationship to general cognitive performance differs in amyloidopathy and synucle...

Full description

Bibliographic Details
Main Authors: Hee Jin Kim, Ji Eun Lee, Soo Jeong Shin, Young Ho Sohn, Phil Hyu Lee
Format: Article
Language:English
Published: Korean Movement Disorder Society 2011-10-01
Series:Journal of Movement Disorders
Subjects:
Online Access:http://e-jmd.org/upload/jmd-4-2-68-4.pdf
_version_ 1827882976541671424
author Hee Jin Kim
Ji Eun Lee
Soo Jeong Shin
Young Ho Sohn
Phil Hyu Lee
author_facet Hee Jin Kim
Ji Eun Lee
Soo Jeong Shin
Young Ho Sohn
Phil Hyu Lee
author_sort Hee Jin Kim
collection DOAJ
description Background and Purpose The substantia innominata (SI) contains the nucleus basalis of Meynert, which is the major source of cholinergic input to the cerebral cortex. We hypothesized that degeneration of the SI and its relationship to general cognitive performance differs in amyloidopathy and synucleinopathy. Methods We used magnetic resonance imaging (MRI)-based volumetric analysis to evaluate the SI volume in patients with amnestic mild cognitive impairment (aMCI), Alzheimer’s disease (AD), Parkinson’s disease-mild cognitive impairment (PD-MCI), PD with dementia (PDD), dementia with Lewy bodies (DLB), and healthy elderly controls. The correlation between SI volume and general cognitive performance, measured using the Korean version of the Mini-Mental State Examination (K-MMSE), was examined. Results Compared to control subjects, the mean normalized SI volume was significantly decreased in all of the other groups. The normalized SI volume did not differ between the subjects with PDD and DLB, whereas it was significantly smaller in subjects with PDD (p = 0.029) and DLB (p = 0.011) compared with AD. In subjects with PD-related cognitive impairment (PD-MCI, PDD, or DLB), there was a significant positive correlation between the SI volume and K-MMSE score (r = 0.366, p < 0.001), whereas no correlation was seen in subjects with AD-related cognitive impairment (aMCI or AD). Conclusions Our data suggest that the SI loss is greater in synucleinopathy-related dementia (PDD or DLB) than in AD and that the contribution of the SI to cognitive performance is greater in synucleinopathy than in amyloidopathy.
first_indexed 2024-03-12T19:04:59Z
format Article
id doaj.art-289b254087424d7fb1cf40db30f3cbe8
institution Directory Open Access Journal
issn 2005-940X
2093-4939
language English
last_indexed 2024-03-12T19:04:59Z
publishDate 2011-10-01
publisher Korean Movement Disorder Society
record_format Article
series Journal of Movement Disorders
spelling doaj.art-289b254087424d7fb1cf40db30f3cbe82023-08-02T06:17:08ZengKorean Movement Disorder SocietyJournal of Movement Disorders2005-940X2093-49392011-10-0142687210.14802/jmd.1101428Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s DiseaseHee Jin KimJi Eun LeeSoo Jeong ShinYoung Ho SohnPhil Hyu LeeBackground and Purpose The substantia innominata (SI) contains the nucleus basalis of Meynert, which is the major source of cholinergic input to the cerebral cortex. We hypothesized that degeneration of the SI and its relationship to general cognitive performance differs in amyloidopathy and synucleinopathy. Methods We used magnetic resonance imaging (MRI)-based volumetric analysis to evaluate the SI volume in patients with amnestic mild cognitive impairment (aMCI), Alzheimer’s disease (AD), Parkinson’s disease-mild cognitive impairment (PD-MCI), PD with dementia (PDD), dementia with Lewy bodies (DLB), and healthy elderly controls. The correlation between SI volume and general cognitive performance, measured using the Korean version of the Mini-Mental State Examination (K-MMSE), was examined. Results Compared to control subjects, the mean normalized SI volume was significantly decreased in all of the other groups. The normalized SI volume did not differ between the subjects with PDD and DLB, whereas it was significantly smaller in subjects with PDD (p = 0.029) and DLB (p = 0.011) compared with AD. In subjects with PD-related cognitive impairment (PD-MCI, PDD, or DLB), there was a significant positive correlation between the SI volume and K-MMSE score (r = 0.366, p < 0.001), whereas no correlation was seen in subjects with AD-related cognitive impairment (aMCI or AD). Conclusions Our data suggest that the SI loss is greater in synucleinopathy-related dementia (PDD or DLB) than in AD and that the contribution of the SI to cognitive performance is greater in synucleinopathy than in amyloidopathy.http://e-jmd.org/upload/jmd-4-2-68-4.pdfThe substantia innominataAlzheimer’s diseaseParkinson’s disease-related cognitive dysfunction
spellingShingle Hee Jin Kim
Ji Eun Lee
Soo Jeong Shin
Young Ho Sohn
Phil Hyu Lee
Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
Journal of Movement Disorders
The substantia innominata
Alzheimer’s disease
Parkinson’s disease-related cognitive dysfunction
title Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
title_full Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
title_fullStr Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
title_full_unstemmed Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
title_short Analysis of the Substantia Innominata Volume in Patients with Parkinson’s Disease with Dementia, Dementia with Lewy Bodies, and Alzheimer’s Disease
title_sort analysis of the substantia innominata volume in patients with parkinson s disease with dementia dementia with lewy bodies and alzheimer s disease
topic The substantia innominata
Alzheimer’s disease
Parkinson’s disease-related cognitive dysfunction
url http://e-jmd.org/upload/jmd-4-2-68-4.pdf
work_keys_str_mv AT heejinkim analysisofthesubstantiainnominatavolumeinpatientswithparkinsonsdiseasewithdementiadementiawithlewybodiesandalzheimersdisease
AT jieunlee analysisofthesubstantiainnominatavolumeinpatientswithparkinsonsdiseasewithdementiadementiawithlewybodiesandalzheimersdisease
AT soojeongshin analysisofthesubstantiainnominatavolumeinpatientswithparkinsonsdiseasewithdementiadementiawithlewybodiesandalzheimersdisease
AT younghosohn analysisofthesubstantiainnominatavolumeinpatientswithparkinsonsdiseasewithdementiadementiawithlewybodiesandalzheimersdisease
AT philhyulee analysisofthesubstantiainnominatavolumeinpatientswithparkinsonsdiseasewithdementiadementiawithlewybodiesandalzheimersdisease